We are live on ! Find out more
CVS icon

CVS Health

1,972 hedge funds and large institutions have $68.1B invested in CVS Health in 2020 Q4 according to their latest regulatory filings, with 277 funds opening new positions, 842 increasing their positions, 720 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 94

38% more call options, than puts

Call options by funds: $1.88B | Put options by funds: $1.36B

30% more funds holding in top 10

Funds holding in top 10: 4660 (+14)

17% more capital invested

Capital invested by funds: $58.2B → $68.1B (+$9.97B)

17% more repeat investments, than reductions

Existing positions increased: 842 | Existing positions reduced: 720

9% more funds holding

Funds holding: 1,8151,972 (+157)

0.1% less ownership

Funds ownership: 76.22%76.12% (-0.1%)

Holders
1,972
Holders Change
+157
Holders Change %
+8.65%
% of All Funds
34.9%
Holding in Top 10
60
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+30.43%
% of All Funds
1.06%
New
277
Increased
842
Reduced
720
Closed
94
Calls
$1.88B
Puts
$1.36B
Net Calls
+$523M
Net Calls Change
-$123M
Name Holding Trade Value Shares
Change
Change in
Stake
MML Investors Services
276
MML Investors Services
Massachusetts
$17.1M +$3.09M +47,508 +23%
CS
277
Candriam SCA
Luxembourg
$17M +$2.81M +43,162 +21%
BSA
278
Braun Stacey Associates
New York
$16.6M +$401K +6,168 +3%
HC
279
Henshaw Capital
Massachusetts
$16.6M -$102K -1,562 -0.6%
CC
280
Cadinha & Co
Hawaii
$16.5M +$15.7M +241,348 New
FAF
281
Första AP-fonden
Sweden
$16.4M +$2.48M +38,200 +19%
Grantham, Mayo, Van Otterloo & Co (GMO)
282
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$16.4M +$15.6M +239,500 New
MSL
283
Mackay Shields LLC
New York
$16.3M -$304K -4,679 -2%
FT
284
Fiduciary Trust
Massachusetts
$16.3M -$123K -1,886 -0.8%
LC
285
Loews Corp
New York
$16.2M -$195K -3,000 -1%
KeyBank National Association
286
KeyBank National Association
Ohio
$16.1M -$1.63M -25,119 -10%
SGA
287
Sector Gamma AS
Norway
$16.1M -$1.04M -15,963 -6%
Public Employees Retirement Association of Colorado
288
Public Employees Retirement Association of Colorado
Colorado
$16M -$524K -8,052 -3%
NIM
289
Northeast Investment Management
Massachusetts
$15.9M +$477K +7,326 +3%
SDJVC
290
St. Denis J. Villere & Co
Louisiana
$15.9M +$623K +9,575 +4%
CGH
291
Crossmark Global Holdings
Texas
$15.8M -$7.67M -117,908 -34%
HCM
292
Hutchinson Capital Management
California
$15.8M -$234K -3,591 -2%
TPSF
293
Texas Permanent School Fund
Texas
$15.8M -$993K -15,261 -6%
RJT
294
Raymond James Trust
Florida
$15.7M +$326K +5,013 +2%
SF
295
Synovus Financial
Georgia
$15.7M +$761K +11,701 +5%
TBA
296
Tower Bridge Advisors
Pennsylvania
$15.7M +$1.09M +16,785 +8%
AAM
297
Advisors Asset Management
Colorado
$15.7M -$14.2K -219 -0.1%
CFB
298
Cullen/Frost Bankers
Texas
$15.6M +$925K +14,217 +7%
RCYC
299
Richard C. Young & Co
Rhode Island
$15.6M +$435K +6,684 +3%
ONB
300
Old National Bancorp
Indiana
$15.5M +$1.03M +15,812 +7%

CVS Hedge Fund Activity: Q4 2020 in Review

1,972 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2020, worth a combined $68.1B — up 17% from $58.2B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 94 closed out — a net gain of 183 holders — while 842 added to existing stakes and 720 trimmed.

The largest buyer was Capital International Investors, adding an estimated $272M. The largest seller was BlackRock, cutting an estimated $508M.

  • 1,972 institutional investors held CVS Health (CVS) as of Q4 2020, up from 1,815 in Q3 2020.
  • Funds reported $68.1B of CVS Health stock for Q4 2020, up 17% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q4 2020 and 94 closed out, a net change of +183 holders.
  • The largest CVS Health buyer in Q4 2020 was Capital International Investors, an estimated $272M added.
  • The largest CVS Health seller in Q4 2020 was BlackRock, an estimated $508M sold.

Based on aggregated 13F filings for Q4 2020.